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Supplementary Table 1. 210 differentially expressed genes identified from two biological 
replicates in PC3 HNF1B cells vs PC3 EV (‘an HNF1B-gene signature’). Initially, 4,547 DEGs 
were identified (false discovery rate (FDR) p<0.01). Only statistically significant genes also 
showing a ≥3-fold change in gene expression were considered in subsequent analyses. 
 
ProbeId Symbol RefSeq logFC adj.P.Val 
ILMN_2076600 ITM2A NM_004867.3 6.71E+00 4.63E-41 
ILMN_1744817 UGT1A1 NM_000463.2 5.60E+00 2.92E-33 
ILMN_1772894 TMEM27 NM_020665.3 5.01E+00 3.19E-30 
ILMN_1662932 LCP1 NM_002298.2 4.32E+00 4.18E-10 
ILMN_2109197 EPB41L3 NM_012307.2 4.21E+00 5.81E-31 
ILMN_2112638 SVEP1 NM_153366.2 4.04E+00 6.88E-25 
ILMN_1712082 GCNT3 NM_004751.1 3.75E+00 2.04E-20 
ILMN_1782389 LAD1 NM_005558.3 3.63E+00 4.10E-13 
ILMN_1713952 C1orf106 NM_018265.1 3.57E+00 3.21E-08 
ILMN_1796059 ANKRD30A XM_001131823.1 3.44E+00 3.41E-27 
ILMN_2212878 ESM1 NM_007036.3 3.40E+00 1.50E-25 
ILMN_1706051 PLD5 NM_152666.1 3.28E+00 1.63E-26 
ILMN_1678842 THBS2 NM_003247.2 3.19E+00 4.80E-25 
ILMN_1653028 COL4A1 NM_001845.4 3.19E+00 1.29E-21 
ILMN_2313672 IL1RL1 NM_003856.2 3.10E+00 1.68E-11 
ILMN_1696339 ZIC2 NM_007129.2 3.03E+00 8.47E-25 
ILMN_1679194 DQ895814 XM_001128725.1 2.90E+00 2.31E-21 
ILMN_1810420 DYSF NM_003494.2 2.90E+00 6.27E-10 
ILMN_1760347 SRGN NM_002727.2 2.89E+00 1.60E-25 
ILMN_1687501 MOXD1 NM_015529.2 2.76E+00 2.93E-23 
ILMN_1794492 HOXC6 NM_004503.3 2.74E+00 1.79E-23 
ILMN_1805665 FLRT3 NM_198391.1 2.66E+00 1.28E-15 
ILMN_1713124 AKR1C3 NM_003739.4 2.64E+00 1.86E-14 
ILMN_1706643 COL6A3 NM_057165.2 2.64E+00 1.39E-23 
ILMN_1686116 THBS1 NM_003246.2 2.62E+00 2.73E-07 
ILMN_1766675 CDH6 NM_004932.2 2.62E+00 9.00E-24 
ILMN_1651826 BASP1 NM_006317.3 2.58E+00 9.07E-07 
ILMN_1771652 BAIAP2L2 NM_025045.4 2.58E+00 2.34E-08 
ILMN_2131861 SOCS2 NM_003877.3 2.58E+00 5.92E-21 
ILMN_1678143 ARHGDIB NM_001175.4 2.52E+00 3.46E-15 
ILMN_1800787 RFTN1 NM_015150.1 2.50E+00 6.41E-19 
ILMN_1705750 TGM2 NM_004613.2 2.49E+00 2.52E-15 
ILMN_1709683 RASSF2 NM_170773.1 2.47E+00 4.18E-10 
ILMN_1715508 NNMT NM_006169.2 2.45E+00 3.47E-08 
ILMN_1659688 LGALS3BP NM_005567.2 2.44E+00 3.34E-20 
ILMN_1704353 IGSF3 NM_001542.2 2.44E+00 5.26E-20 
ILMN_1761733 HLA-DMB NM_002118.3 2.42E+00 1.45E-21 
ILMN_1715684 LAMB3 NM_000228.2 2.40E+00 2.02E-17 
ILMN_2157099 CCNA1 NM_003914.2 2.39E+00 3.87E-18 
ILMN_1666733 IL8 NM_000584.2 2.39E+00 4.65E-08 
ILMN_1808715 LOC389300 XM_943175.1 2.39E+00 3.99E-09 
 ILMN_1712684 FAM20C NM_020223.2 2.36E+00 8.39E-08 
ILMN_2410713 FGFR4 NM_213647.1 2.35E+00 2.73E-06 
ILMN_1781155 LYN NM_002350.1 2.33E+00 1.00E-21 
ILMN_1741430 MAGEA10 NM_021048.3 2.33E+00 2.85E-22 
ILMN_1723092 CRB3 NM_139161.2 2.32E+00 2.73E-07 
ILMN_1776516 ITPKA NM_002220.1 2.30E+00 9.33E-21 
ILMN_1696702 NEO1 NM_002499.1 2.30E+00 1.87E-19 
ILMN_1698725 FRMD3 NM_174938.3 2.30E+00 1.22E-22 
ILMN_2190084 VAMP8 NM_003761.2 2.30E+00 1.12E-06 
ILMN_1724832 OVOL2 NM_021220.2 2.30E+00 1.81E-09 
ILMN_1687757 AKR1C1 NM_001818.2 2.29E+00 3.25E-16 
ILMN_1674908 HOXB5 NM_002147.3 2.28E+00 6.42E-21 
ILMN_1748303 MUC5AC XM_001134429.1 2.28E+00 2.12E-21 
ILMN_2302757 FCGBP NM_003890.1 2.28E+00 6.96E-18 
ILMN_1782939 DQ894588 NM_000477.3 2.25E+00 4.21E-21 
ILMN_2083946 TGFA NM_003236.1 2.24E+00 4.00E-19 
ILMN_1854469 AK130049  2.23E+00 1.65E-20 
ILMN_1778401 HLA-B NM_005514.5 2.21E+00 2.35E-17 
ILMN_1658498 SLC44A3 NM_152369.2 2.15E+00 8.34E-18 
ILMN_1792978 HAS2 NM_005328.1 2.13E+00 8.98E-21 
ILMN_1781761 ENPP4 NM_014936.3 2.11E+00 9.06E-20 
ILMN_2367258 SMOX NM_175840.1 2.11E+00 2.40E-05 
ILMN_2285404 DMKN NM_033317.2 2.09E+00 2.51E-06 
ILMN_1706483 C1orf116 NM_023938.5 2.08E+00 6.18E-09 
ILMN_1779234 CXCL6 NM_002993.2 2.07E+00 2.37E-12 
ILMN_2412336 AKR1C2 NM_001354.4 2.07E+00 2.30E-09 
ILMN_2199768 SLITRK4 NM_173078.2 2.06E+00 2.04E-20 
ILMN_1667199 SQRDL NM_021199.2 2.06E+00 5.64E-07 
ILMN_1808379 PLCD4 NM_032726.2 2.05E+00 5.41E-21 
ILMN_2069632 GTSF1 NM_144594.1 2.04E+00 3.91E-20 
ILMN_1695404 LY6E NM_002346.1 2.04E+00 1.63E-19 
ILMN_1744937 PTPRM NM_002845.2 2.03E+00 9.38E-17 
ILMN_1672148 EU176471 NM_020299.3 2.03E+00 5.30E-23 
ILMN_1733998 DHRS9 NM_005771.3 2.03E+00 4.19E-08 
ILMN_1678049 FGB NM_005141.2 2.02E+00 2.12E-21 
ILMN_1804351 FZD7 NM_003507.1 2.00E+00 2.29E-17 
ILMN_1730645 TMEFF2 NM_016192.2 1.99E+00 1.79E-23 
ILMN_2139396 IGDCC4 NM_020962.1 1.97E+00 8.28E-20 
ILMN_1663866 TGFBI NM_000358.1 1.95E+00 2.88E-18 
ILMN_1703886 SLC16A2 NM_006517.2 1.95E+00 1.34E-05 
ILMN_2314169 PTHLH NM_198965.1 1.94E+00 2.38E-12 
ILMN_1718285 HOXC8 NM_022658.3 1.94E+00 9.52E-18 
ILMN_1854469   1.93E+00 5.02E-04 
ILMN_1707339 BTG3 NM_006806.3 1.92E+00 2.08E-20 
ILMN_1684886 VCX NM_013452.2 1.92E+00 3.92E-09 
ILMN_1763837 ANPEP NM_001150.1 1.91E+00 1.63E-17 
 ILMN_1782439 CNN3 NM_001839.2 1.90E+00 2.00E-18 
ILMN_2166716 VCX-C NM_001001888.1 1.89E+00 1.69E-07 
ILMN_1791531 FA2H NM_024306.2 1.87E+00 1.61E-06 
ILMN_1672148 AKR1B10 NM_020299.3 1.86E+00 5.84E-07 
ILMN_2188264 CYR61 NM_001554.3 1.85E+00 1.17E-16 
ILMN_1675684 APOBEC3C NM_014508.2 1.85E+00 2.51E-06 
ILMN_1655614 DSP NM_001008844.1 1.83E+00 6.31E-17 
ILMN_1673769 KCNG1 NM_002237.3 1.83E+00 1.14E-05 
ILMN_1718766 MT1F NM_005949.2 1.83E+00 4.37E-04 
ILMN_2407824 ATP1B1 NM_001001787.1 1.83E+00 9.74E-18 
ILMN_1789502 GPC4 NM_001448.2 1.82E+00 2.77E-19 
ILMN_2413816 GRB14 NM_004490.2 1.82E+00 7.44E-18 
ILMN_1701933 SNCA NM_007308.1 1.81E+00 3.23E-18 
ILMN_1679194 UGT2B7 XM_001128725.1 1.81E+00 2.30E-09 
ILMN_2406035 LAMA3 NM_198129.1 1.81E+00 2.20E-10 
ILMN_1752520 SLFN11 NM_152270.2 1.80E+00 3.42E-17 
ILMN_2352090 GPRC5C NM_018653.3 1.79E+00 1.87E-03 
ILMN_2160210 EPCAM NM_002354.1 1.79E+00 3.09E-19 
ILMN_1784661 KIAA1412 NM_013390.1 1.78E+00 8.99E-18 
ILMN_1667711 DQ895783 NM_007069.2 1.78E+00 2.03E-19 
ILMN_2081087 HSPA12A NM_025015.2 1.77E+00 9.33E-21 
ILMN_1706498 DSE NM_013352.2 1.77E+00 1.27E-17 
ILMN_1708093 ARHGEF5 NM_005435.3 1.76E+00 1.09E-04 
ILMN_2175912 ITGB2 NM_000211.2 1.75E+00 1.75E-08 
ILMN_1703572 PCDH20 NM_022843.2 1.74E+00 2.29E-20 
ILMN_2366642 VCX3A NM_016379.2 1.74E+00 4.32E-08 
ILMN_1675797 EPDR1 NM_017549.3 1.74E+00 4.05E-18 
ILMN_1705403 CYP2S1 NM_030622.6 1.73E+00 6.30E-04 
ILMN_2214473 ARHGEF5L NM_001003702.1 1.73E+00 8.42E-18 
ILMN_2214473 FLJ43692 NM_001003702.1 1.70E+00 2.15E-07 
ILMN_1677814 ABCC3 NM_003786.2 1.69E+00 1.56E-18 
ILMN_1666845 KRT17 NM_000422.1 1.69E+00 2.73E-06 
ILMN_1685714 INHBB NM_002193.1 1.69E+00 3.10E-20 
ILMN_1707975 SERPIND1 NM_000185.3 1.69E+00 3.66E-20 
ILMN_1672662 SLC20A1 NM_005415.3 1.67E+00 1.40E-14 
ILMN_1663919 TFF2 NM_005423.3 1.66E+00 1.96E-17 
ILMN_1769245 GLIPR1 NM_006851.2 1.64E+00 2.63E-17 
ILMN_1663080 LFNG NM_001040167.1 1.62E+00 7.95E-08 
ILMN_1780132 PELI2 NM_021255.2 1.62E+00 8.41E-16 
ILMN_1674415 LOC650463 XM_939552.1 1.62E+00 1.82E-07 
ILMN_1769575 JAM3 NM_032801.3 1.60E+00 3.07E-17 
ILMN_1656057 PLAU NM_002658.2 1.60E+00 1.11E-12 
ILMN_1814327 AGTR1 NM_000685.4 1.60E+00 5.26E-20 
ILMN_1653856 UBASH3B NM_032873.3 1.60E+00 8.56E-15 
ILMN_1873278 FAM155A XM_001133620.1 1.59E+00 3.69E-19 
ILMN_1799198 OTUB2 NM_023112.2 1.59E+00 6.81E-05 
 ILMN_1801216 S100P NM_005980.2 1.59E+00 4.71E-04 
ILMN_1800697 LDB2 NM_001290.2 1.59E+00 8.07E-08 
ILMN_1743130 PTGFRN NM_020440.2 1.58E+00 2.35E-17 
ILMN_1664660 GAGE1 NM_001098409.1 1.57E+00 5.09E-17 
ILMN_1705442 CMTM3 NM_144601.2 1.57E+00 1.88E-16 
ILMN_1699772 RRAGD NM_021244.3 1.57E+00 9.82E-16 
ILMN_1691341 IL7R XM_937367.1 1.56E+00 1.50E-12 
ILMN_2251766 IL1R2 NM_173343.1 1.56E+00 1.75E-07 
ILMN_1667114 LOC388524 NR_003662.1 1.56E+00 2.64E-08 
ILMN_1760414 AADAC NM_001086.2 1.54E+00 1.15E-16 
ILMN_1724994 COL4A2 NM_001846.2 1.54E+00 6.83E-13 
ILMN_1668194 LMTK3 XM_936372.2 1.53E+00 2.32E-04 
ILMN_1772466 SH2D3A NM_005490.1 1.53E+00 6.35E-06 
ILMN_1656560 DKFZP564O0823 NM_015393.2 1.52E+00 2.44E-16 
ILMN_1674985 TMEM51 NM_018022.1 1.52E+00 3.98E-17 
ILMN_1656910 TRIM6 NM_058166.3 1.52E+00 5.99E-12 
ILMN_1805561 SLC14A1 NM_015865.2 1.51E+00 8.44E-14 
ILMN_1672589 SEMA4B NM_198925.1 1.51E+00 6.26E-15 
ILMN_1852151 BX110351  1.50E+00 3.55E-16 
ILMN_1730639 SLC22A15 NM_018420.1 1.50E+00 5.03E-15 
ILMN_1667068 ZC3HAV1 NM_020119.3 -2.69E-01 9.95E-03 
ILMN_2089656 C1orf107 NM_014388.5 -2.93E-01 9.94E-03 
ILMN_1774083 TRIAP1 NM_016399.2 -2.97E-01 9.95E-03 
ILMN_1655497 EIF4B NM_001417.4 -3.10E-01 9.96E-03 
ILMN_1764127 NPHP1 NM_207181.1 -3.16E-01 9.97E-03 
ILMN_1770031 ABHD10 NM_018394.1 -3.58E-01 9.94E-03 
ILMN_1660871 NEK6 NM_014397.3 -3.64E-01 9.94E-03 
ILMN_1725594 C10orf97 NM_024948.2 -1.50E+00 2.10E-15 
ILMN_1704294 CDH3 NM_001793.3 -1.50E+00 6.05E-12 
ILMN_1664798 GRHPR NM_012203.1 -1.51E+00 7.72E-18 
ILMN_1808661 TOMM5 NM_001001790.2 -1.54E+00 1.46E-16 
ILMN_1786197 NR2F1 NM_005654.4 -1.54E+00 5.67E-06 
ILMN_1777660 RNF144 NM_014746.2 -1.56E+00 1.20E-05 
ILMN_1682273 SHISA3 NM_001080505.1 -1.58E+00 2.20E-07 
ILMN_1781010 ARHGEF3 NM_019555.1 -1.60E+00 6.99E-16 
ILMN_1807894 SLC7A8 NM_182728.1 -1.60E+00 6.05E-19 
ILMN_1723969 PLCB1 NM_015192.2 -1.61E+00 9.00E-17 
ILMN_1787932 GPR110 NM_025048.2 -1.61E+00 1.06E-09 
ILMN_2148913 TMEM45A NM_018004.1 -1.62E+00 3.47E-12 
ILMN_1708936 EXOSC3 NM_016042.2 -1.62E+00 8.42E-18 
ILMN_1678934 POLR1E NM_022490.1 -1.62E+00 7.92E-15 
ILMN_1724789 CD59 NM_000611.4 -1.66E+00 4.75E-07 
ILMN_2380938 SYT7 NM_004200.2 -1.66E+00 1.72E-15 
ILMN_2138745 C14orf37 NM_001001872.2 -1.67E+00 1.17E-16 
ILMN_1725139 CA9 NM_001216.1 -1.69E+00 5.43E-12 
ILMN_1677273 TH NM_199293.2 -1.70E+00 5.15E-05 
 ILMN_1753005 RELN NM_005045.2 -1.71E+00 6.75E-20 
ILMN_1788250 LDOC1 NM_012317.2 -1.71E+00 4.93E-18 
ILMN_1814221 NPTX1 NM_002522.2 -1.73E+00 2.25E-18 
ILMN_1760247 CD70 NM_001252.3 -1.73E+00 1.19E-05 
ILMN_1685699 PRSS3 NM_002771.2 -1.75E+00 9.89E-19 
ILMN_1721247 KRT75 NM_004693.2 -1.75E+00 1.33E-18 
ILMN_2169383 REG4 NM_032044.2 -1.79E+00 1.51E-05 
ILMN_1800540 CD55 NM_000574.2 -1.80E+00 2.97E-03 
ILMN_1720048 CCL2 NM_002982.3 -1.82E+00 2.59E-08 
ILMN_1744381 SERPINE1 NM_000602.1 -1.84E+00 1.60E-06 
ILMN_1687384 IFI6 NM_022873.2 -1.85E+00 1.51E-03 
ILMN_1777660 RNF144A NM_014746.2 -1.90E+00 3.88E-20 
ILMN_1713266 FAM46C NM_017709.3 -1.94E+00 2.16E-19 
ILMN_2331231 TNFRSF6B NM_032945.2 -1.95E+00 3.44E-07 
ILMN_1768646 AK056814 NM_182510.1 -1.95E+00 1.01E-19 
ILMN_1656415 CDKN2C NM_078626.2 -1.97E+00 2.37E-19 
ILMN_1676563 HTRA1 NM_002775.3 -2.07E+00 3.88E-07 
ILMN_1726597 FAM65B NM_015864.2 -2.10E+00 8.42E-21 
ILMN_1758067 RGS4 NM_005613.3 -2.10E+00 3.17E-06 
ILMN_1765860 DOCK11 NM_144658.3 -2.12E+00 2.27E-22 
ILMN_1683263 TSPAN8 NM_004616.2 -2.15E+00 9.15E-05 
ILMN_1688780 S100A4 NM_019554.2 -2.17E+00 5.67E-06 
ILMN_1711988 KCNK12 NM_022055.1 -2.38E+00 5.69E-25 
ILMN_1727466 KCNMB4 NM_014505.4 -2.44E+00 1.35E-21 
ILMN_1738742 PLAT NM_000930.2 -2.51E+00 5.50E-09 
ILMN_1740426 RASD1 NM_016084.3 -2.53E+00 9.15E-25 
ILMN_1666222 PHACTR3 NM_183246.1 -2.71E+00 1.09E-07 
ILMN_1674063 OAS2 NM_016817.2 -2.79E+00 1.46E-03 
ILMN_1805376 KCNJ6 NM_002240.2 -3.08E+00 3.16E-26 
ILMN_2180232 URP NM_198152.2 -3.19E+00 1.34E-26 
ILMN_1662358 MX1 NM_002462.2 -3.36E+00 1.98E-04 
ILMN_1725417 NELL2 NM_006159.1 -3.49E+00 7.96E-31 
ILMN_2058782 IFI27 NM_005532.3 -3.83E+00 4.22E-04 
Supplementary Table 2. Data sets included in the gene set enrichment analysis of 210 



















Glinsky et al., 2004 Benign-primary PC Bottom -1.02 0.445 
 
 
Varambally et al., 2005 
Benign-primary PC Top 1.36 <0.001 
Benign-metastatic PC Top 1.60 <0.001 
Primary-metastatic PC Top 1.47 <0.001 
Tomlins et al., 2007 Normal-primary PC Top 1.25 0.015 
 
 
Taylor et al., 2010 
Normal-primary PC top 1.79 <0.001 
Normal-metastatic PC Top 1.78 <0.001 
Primary-metastatic PC Top 1.47 <0.001 
 
 
Grasso et al., 2012 
Benign-primary PC Top 1.75 <0.001 
Benign-metastatic PC Top 1.94 <0.001 
Primary-metastatic PC Top 1.80 <0.001 
Bowen et al., 2009 Normal-primary OC Top 1.13 0.012 
Partheen et al., 2006 5-year survivors-deceased OC Top 1.14 0.045 
 
* Study expression profiles for each sample group comparison were ranked in ascending 
order according to t-statistic, so over- or under-expressed targets could be distinguished 
using family-wise error rate (FWER) p-value (See  www.broadinstitute.org/gsea and 
(Benjamini & Hochberg, 1995) [8]). Here, the ‘top’ of the distribution corresponds to the 
first phenotype (benign); the bottom of the distribution corresponds to the second 
phenotype (disease state).
Supplementary Table 3. 129 key, functionally relevant genes were identified by ‘leading edge’ 




Symbol Entrez Gene Name 
ABCC3 ATP-binding cassette, sub-family C (CFTR/MRP), member 3 
ABHD10 abhydrolase domain containing 10 
AGTR1 angiotensin II receptor, type 1 
AKR1C1 aldo-keto reductase family 1, member C1 
AKR1C2 aldo-keto reductase family 1, member C2 
AKR1C3 aldo-keto reductase family 1, member C3 
ANPEP alanyl (membrane) aminopeptidase 
APOBEC3C apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C 
ARHGDIB Rho GDP dissociation inhibitor (GDI) beta 
ARHGEF3 Rho guanine nucleotide exchange factor (GEF) 3 
ATP1B1 ATPase, Na+/K+ transporting, beta 1 polypeptide 
BASP1 brain abundant, membrane attached signal protein 1 
BTG3 BTG family, member 3 
C14orf37 chromosome 14 open reading frame 37 
C1orf106 chromosome 1 open reading frame 106 
C1orf116 chromosome 1 open reading frame 116 
CA9 carbonic anhydrase IX 
CCL2 chemokine (C-C motif) ligand 2 
CD55 CD55 molecule, decay accelerating factor for complement (Cromer blood group) 
CD59 CD59 molecule, complement regulatory protein 
CDH3 cadherin 3, type 1, P-cadherin (placental) 
CDH6 cadherin 6, type 2, K-cadherin (fetal kidney) 
CDKN2C cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) 
CNN3 calponin 3, acidic 
COL4A1 collagen, type IV, alpha 1 
COL4A2 collagen, type IV, alpha 2 
COL6A3 collagen, type VI, alpha 3 
CXCL6 chemokine (C-X-C motif) ligand 6 
CYR61 cysteine-rich, angiogenic inducer, 61 
DHRS9 dehydrogenase/reductase (SDR family) member 9 
DMKN dermokine 
DOCK11 dedicator of cytokinesis 11 
DSE dermatan sulfate epimerase 
DSP desmoplakin 
DYSF dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive) 
EIF4B eukaryotic translation initiation factor 4B 
ENPP4 ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative) 
 EPB41L3 erythrocyte membrane protein band 4.1-like 3 
EPDR1 ependymin related protein 1 (zebrafish) 
FA2H fatty acid 2-hydroxylase 
FAM155A family with sequence similarity 155, member A 
FAM20C family with sequence similarity 20, member C 
FAM46C family with sequence similarity 46, member C 
FAM65B family with sequence similarity 65, member B 
FCGBP Fc fragment of IgG binding protein 
FLRT3 fibronectin leucine rich transmembrane protein 3 
FZD7 frizzled family receptor 7 
GLIPR1 GLI pathogenesis-related 1 
GPC4 glypican 4 
GRHPR glyoxylate reductase/hydroxypyruvate reductase 
HAS2 hyaluronan synthase 2 
HLA-B major histocompatibility complex, class I, B 
HLA-DMB major histocompatibility complex, class II, DM beta 
HOXB5 homeobox B5 
HSPA12A heat shock 70kDa protein 12A 
HTRA1 HtrA serine peptidase 1 
IFI27 interferon, alpha-inducible protein 27 
IFI6 interferon, alpha-inducible protein 6 
IGDCC4 immunoglobulin superfamily, DCC subclass, member 4 
IGSF3 immunoglobulin superfamily, member 3 
IL1R2 interleukin 1 receptor, type II 
IL1RL1 interleukin 1 receptor-like 1 
IL7R interleukin 7 receptor 
ITM2A integral membrane protein 2A 
ITPKA inositol-trisphosphate 3-kinase A 
JAM3 junctional adhesion molecule 3 
KCNG1 potassium voltage-gated channel, subfamily G, member 1 
KCNJ6 potassium inwardly-rectifying channel, subfamily J, member 6 
KCNMB4 potassium large conductance calcium-activated channel, subfamily M, beta member 4 
KRT17 keratin 17 
KRT75 keratin 75 
LAMA3 laminin, alpha 3 
LAMB3 laminin, beta 3 
LCP1 lymphocyte cytosolic protein 1 (L-plastin) 
LDB2 LIM domain binding 2 
LDOC1 leucine zipper, down-regulated in cancer 1 
LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 
LMTK3 lemur tyrosine kinase 3 
LY6E lymphocyte antigen 6 complex, locus E 
MOXD1 monooxygenase, DBH-like 1 
MT1F metallothionein 1F 
MX1 myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) 
NEK6 NIMA-related kinase 6 
 NELL2 NEL-like 2 (chicken) 
NEO1 neogenin 1 
NPHP1 nephronophthisis 1 (juvenile) 
NPTX1 neuronal pentraxin I 
NR2F1 nuclear receptor subfamily 2, group F, member 1 
OAS2 2'-5'-oligoadenylate synthetase 2, 69/71kDa 
PCDH20 protocadherin 20 
PELI2 pellino E3 ubiquitin protein ligase family member 2 
PLAT plasminogen activator, tissue 
PLAU plasminogen activator, urokinase 
PLCB1 phospholipase C, beta 1 (phosphoinositide-specific) 
PLCD4 phospholipase C, delta 4 
PLD5 phospholipase D family, member 5 
POLR1E polymerase (RNA) I polypeptide E, 53kDa 
PTGFRN prostaglandin F2 receptor negative regulator 
PTPRM protein tyrosine phosphatase, receptor type, M 
RASD1 RAS, dexamethasone-induced 1 
RASSF2 Ras association (RalGDS/AF-6) domain family member 2 
REG4 regenerating islet-derived family, member 4 
RFTN1 raftlin, lipid raft linker 1 
RGS4 regulator of G-protein signaling 4 
S100A4 S100 calcium binding protein A4 
SEMA4B sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short 
cytoplasmic domain, (semaphorin) 4B 
SH2D3A SH2 domain containing 3A 
SLC14A1 solute carrier family 14 (urea transporter), member 1 (Kidd blood group) 
SLC16A2 solute carrier family 16, member 2 (thyroid hormone transporter) 
SLC22A15 solute carrier family 22, member 15 
SLC44A3 solute carrier family 44, member 3 
SLC7A8 solute carrier family 7 (amino acid transporter light chain, L system), member 8 
SLFN11 schlafen family member 11 
SLITRK4 SLIT and NTRK-like family, member 4 
SNCA synuclein, alpha (non A4 component of amyloid precursor) 
SOCS2 suppressor of cytokine signaling 2 
SQRDL sulfide quinone reductase-like (yeast) 
SRGN serglycin 
TGFA transforming growth factor, alpha 
TGFBI transforming growth factor, beta-induced, 68kDa 
THBS1 thrombospondin 1 
TMEM27 transmembrane protein 27 
TMEM45A transmembrane protein 45A 
TMEM51 transmembrane protein 51 
TNFRSF6B tumor necrosis factor receptor superfamily, member 6b, decoy 
TRIAP1 TP53 regulated inhibitor of apoptosis 1 
TRIM6 tripartite motif containing 6 
TSPAN8 tetraspanin 8 









































































Supplementary Table 4. GSEA of HNF1B gene signature in Partheen et al. (2006) OvCa 
dataset [6]. SLC14A1 is marginally significant and highlighted in bold (truncated at 100). 
The rank metric score is a measure of the position of the gene (HNF1B gene signature) in 
the ranked gene list (clinical expression dataset). The enrichment score reflects the 
degree to which a gene set is overrepresented at the top or bottom of a ranked list of 
genes. 
 
PROBE RANK METRIC SCORE RUNNING ES CORE ENRICHMENT 
CDH3 4.644183159 0.03440123 Yes 
SH2D3A 3.423933029 0.056671757 Yes 
SOCS2 2.936975718 0.07309105 Yes 
S100P 2.658154249 0.08592945 Yes 
BAIAP2L2 2.601016045 0.10422841 Yes 
NEK6 2.582150698 0.12316636 Yes 
KCNK12 2.354278564 0.13223599 Yes 
ITM2A 2.295039177 0.14568613 Yes 
FA2H 2.27689743 0.1616964 Yes 
SMOX 2.048242807 0.1617306 Yes 
SNCA 1.987776756 0.17145751 Yes 
PHACTR3 1.950957775 0.18374643 Yes 
PLAT 1.759124875 0.17905824 Yes 
CA9 1.746774673 0.19095118 Yes 
APOBEC3C 1.745029688 0.20396629 Yes 
HTRA1 1.648367882 0.20639418 Yes 
CYR61 1.6014781 0.21208899 Yes 
NELL2 1.54125905 0.21577127 Yes 
NPTX1 1.48114574 0.21921562 Yes 
SLC7A8 1.38239634 0.21610136 Yes 
ANPEP 1.368070245 0.22458677 Yes 
TGFA 1.363510013 0.23431513 Yes 
KRT17 1.220762372 0.22055213 No 
SLC14A1 1.137140989 0.21396679 No 
PCDH20 0.985651016 0.19297737 No 
C1orf107 0.968404114 0.19718853 No 
INHBB 0.968165517 0.20430695 No 
FGB 0.939397454 0.20610106 No 
NR2F1 0.867946327 0.19799368 No 
LAD1 0.836478651 0.1968165 No 
NNMT 0.824350417 0.20016025 No 
FGFR4 0.788387001 0.19869338 No 
CDKN2C 0.767320096 0.19884232 No 
SERPIND1 0.766605139 0.20437828 No 
DOCK11 0.734304667 0.20193821 No 
 PLCB1 0.723803222 0.20523748 No 
JAM3 0.721637964 0.21001051 No 
TSPAN8 0.714207709 0.21366353 No 
CCL2 0.668273807 0.20789021 No 
THBS1 0.660217524 0.21113837 No 
SLITRK4 0.654016793 0.21462382 No 
C10orf97 0.634625554 0.21448721 No 
SVEP1 0.577409685 0.2029949 No 
EXOSC3 0.56545943 0.20375864 No 
HOXB5 0.550719142 0.20455377 No 
AKR1C1 0.533076704 0.20408134 No 
HOXC6 0.509748161 0.20144732 No 
SQRDL 0.459299028 0.19233309 No 
ITGB2 0.439326257 0.18973859 No 
EPB41L3 0.423674345 0.1883748 No 
ARHGEF3 0.413964123 0.18963438 No 
UGT2B7 0.399315774 0.18830079 No 
GLIPR1 0.381995916 0.18556017 No 
ENPP4 0.368608475 0.18463486 No 
VAMP8 0.362636358 0.1857224 No 
ZIC2 0.347321212 0.18357317 No 
ANKRD30A 0.337889284 0.18291417 No 
TGM2 0.322476983 0.1806496 No 
LYN 0.306531936 0.17904593 No 
EIF4B 0.239444152 0.16168444 No 
RRAGD 0.190574139 0.14722028 No 
RASSF2 0.183523953 0.14675178 No 
AGTR1 0.182779357 0.14812244 No 
RGS4 0.122917742 0.12953237 No 
PTGFRN 0.119115904 0.12929039 No 
PLCD4 0.099402577 0.12350821 No 
OVOL2 0.076157562 0.11819029 No 
CD59 0.057318468 0.11280204 No 
PTHLH 0.033293124 0.104750305 No 
IGSF3 0.027114799 0.10339269 No 
DHRS9 0.024083793 0.10236711 No 
TRIM6 0.003298137 0.09657376 No 
PELI2 -0.036220271 0.0828678 No 
PLAU -0.054781534 0.076254345 No 
TGFBI -0.121444434 0.054034654 No 
CCNA1 -0.177204713 0.036915954 No 
POLR1E -0.187265486 0.035198368 No 
BTG3 -0.197031721 0.033483073 No 
FAM46C -0.208382994 0.031498138 No 
KCNG1 -0.215771616 0.0309167 No 
SERPINE1 -0.253528953 0.021678433 No 
 S100A4 -0.267521471 0.019853173 No 
LY6E -0.289053023 0.015422242 No 
CRB3 -0.309267402 0.011639564 No 
TMEM51 -0.313842505 0.011864519 No 
HOXC8 -0.315892488 0.013452937 No 
DYSF -0.322591901 0.013033981 No 
LGALS3BP -0.340222806 0.009767249 No 
SLC16A2 -0.347391248 0.010385691 No 
IL1RL1 -0.359550953 0.009676277 No 
ARHGDIB -0.408525288 -0.003366318 No 
SYT7 -0.429696351 -0.00518161 No 
IL1R2 -0.461387247 -0.011938759 No 
OTUB2 -0.5153144 -0.023400063 No 
HAS2 -0.552036941 -0.030115996 No 
GRHPR -0.566966832 -0.031398557 No 
COL6A3 -0.594832182 -0.03396215 No 
MAGEA10 -0.619593918 -0.036623858 No 
TFF2 -0.654447377 -0.043139428 No 
Supplementary Table 5. GSEA of HNF1B gene signature in Bowen et al. (2009) OvCa dataset 
[7]. FLRT3 is highlighted in the leading edge core set (bold); SLC14A1 is marginally significant 
(truncated at 100). 
 
PROBE RANK METRIC SCORE RUNNING ES CORE ENRICHMENT 
NELL2 16.04439354 0.045874104 Yes 
HTRA1 6.155093193 0.058487598 Yes 
FZD7 5.499065399 0.07119067 Yes 
TSPAN8 5.060777664 0.08335961 Yes 
SQRDL 4.971918106 0.09723976 Yes 
NPTX1 4.715147495 0.10875601 Yes 
HOXC6 4.487001896 0.11971581 Yes 
RGS4 4.328110695 0.13098826 Yes 
SLFN11 4.297151566 0.14298706 Yes 
SHISA3 4.291514874 0.15516149 Yes 
PLD5 4.089894295 0.16455448 Yes 
FLRT3 3.907161713 0.17356879 Yes 
ITM2A 3.829917431 0.183273 Yes 
CXCL6 3.59756875 0.18958063 Yes 
TRIM6 2.910607815 0.18323483 Yes 
EPB41L3 2.869237661 0.19028813 Yes 
SLC44A3 2.671762466 0.1916958 Yes 
PHACTR3 2.44990468 0.1900245 Yes 
AKR1C3 2.373610973 0.19355161 Yes 
SLITRK4 2.318780422 0.19821617 Yes 
FAM155A 2.295049429 0.20343602 Yes 
TMEM27 2.232731581 0.20684794 Yes 
DOCK11 2.094020844 0.20578885 Yes 
EPDR1 2.027317762 0.20875724 Yes 
SLC16A2 1.957433939 0.21071094 Yes 
RASSF2 1.947236776 0.21584707 Yes 
PTHLH 1.864156604 0.21662334 Yes 
FAM65B 1.833304167 0.2208585 Yes 
SLC14A1 1.688186169 0.21696137 No 
CYR61 1.64270854 0.21892595 No 
TMEM45A 1.602889419 0.22077669 No 
NR2F1 1.422489166 0.21147028 No 
GRB14 1.379568219 0.21229902 No 
CA9 1.378596902 0.21614483 No 
SERPIND1 1.340410113 0.21681368 No 
GPC4 1.293864727 0.21667838 No 
HLA-B 1.164816141 0.20836085 No 
ABHD10 1.130360961 0.20818946 No 
BASP1 1.030596375 0.20130965 No 
LCP1 1.000961781 0.20096003 No 
ARHGEF3 0.933593988 0.19663098 No 
 ENPP4 0.772798598 0.17856447 No 
SNCA 0.682321727 0.16901119 No 
APOBEC3C 0.665064156 0.16865984 No 
SLC22A15 0.626421273 0.16503435 No 
AKR1C1 0.625660777 0.16672738 No 
CDH3 0.623450518 0.16817442 No 
PELI2 0.503625274 0.15125564 No 
EIF4B 0.495122045 0.15147294 No 
PLCD4 0.486271441 0.15123352 No 
AGTR1 0.466722369 0.15017128 No 
RFTN1 0.39131096 0.13844378 No 
LAMB3 0.386880636 0.13897474 No 
FA2H 0.366004616 0.13661791 No 
SEMA4B 0.311142355 0.12892734 No 
CNN3 0.251050234 0.118140966 No 
KCNMB4 0.242720112 0.11710933 No 
AADAC 0.229054958 0.1153196 No 
AKR1B10 0.166647568 0.104052246 No 
S100P 0.152569383 0.10170829 No 
NNMT 0.132835001 0.09830131 No 
GCNT3 0.107950538 0.09319341 No 
TFF2 -0.011683613 0.068924256 No 
RASD1 -0.044371516 0.06277177 No 
CCNA1 -0.080429859 0.053894263 No 
GAGE1 -0.130313456 0.04328996 No 
GLIPR1 -0.136081874 0.042336892 No 
PTGFRN -0.16459024 0.0369116 No 
C14orf37 -0.218766615 0.024690775 No 
RRAGD -0.237667844 0.020816581 No 
SERPINE1 -0.27892527 0.01173967 No 
CDKN2C -0.284475297 0.011498493 No 
PLCB1 -0.290996999 0.010604885 No 
RELN -0.296968639 0.010063891 No 
CD59 -0.302829593 0.009491719 No 
FAM46C -0.355363816 -0.002050944 No 
AKR1C2 -0.362437367 -0.002788223 No 
ZIC2 -0.383538544 -0.007060223 No 
FAM20C -0.422514051 -0.017068736 No 
LDOC1 -0.435382158 -0.019131342 No 
VAMP8 -0.457555234 -0.023479318 No 
JAM3 -0.484945387 -0.02928287 No 
PLAU -0.516204596 -0.036195394 No 
IGSF3 -0.516380012 -0.03471896 No 
DHRS9 -0.583560407 -0.05193646 No 
HOXC8 -0.590739131 -0.05226065 No 
LGALS3BP -0.64788568 -0.06550744 No 
 LY6E -0.675888658 -0.07124439 No 
CCL2 -0.679559946 -0.07035594 No 
DSP -0.684263945 -0.06950197 No 
HSPA12A -0.696170509 -0.070675135 No 
SLC20A1 -0.733554721 -0.077876955 No 
GTSF1 -0.7356264 -0.07630093 No 
FGFR4 -0.783246398 -0.08777061 No 
PCDH20 -0.794070423 -0.08837625 No 
IGDCC4 -0.802874148 -0.08871704 No 
DSE -0.816198409 -0.08940321 No 
CD70 -0.821981072 -0.08853896 No 
MX1 -0.829278529 -0.08822905 No 
Supplementary Table 6. Consensus set of 37 core enrichment genes common between 
prostate and ovarian cancer GSEA ranked by order in gene list, where only the highest 
ranking study per gene is referenced. See also Supplementary Figure 16. 
 
Gene Rank in referenced 
gene list 
Rank - metric score Running ES Study 
NELL2 1 16.044 0.046 Bowen et al., 2009 
CDH3 6 4.644 0.034 Partheen et al., 2006 
PLD5 9 12.000 0.023 Varambally et al., 2005 
CYR61 12 26.362 0.035 Varambally et al., 2005 
FLRT3 25 22.500 0.051 Varambally et al., 2005 
APOBEC3C 34 11.800 0.018 Taylor et al., 2010 
SLC16A2 37 7.460 0.038 Grasso et al., 2012 
SOCS2 41 8.637 0.017 Taylor et al., 2010 
SH2D3A 55 3.424 0.057 Partheen et al., 2006 
RGS4 73 7.590 0.137 Varambally et al., 2005 
HTRA1 105 6.155 0.058 Bowen et al., 2009 
TRIM6 118 12.600 0.050 Grasso et al., 2012 
FZD7 131 12.500 0.067 Grasso et al., 2012 
SNCA 148 11.526 0.030 Grasso et al., 2012 
SQRDL 189 10.943 0.061 Grasso et al., 2012 
TSPAN8 218 5.061 0.083 Bowen et al., 2009 
FAM155A 236 5.680 0.216 Varambally et al., 2005 
NEK6 261 2.582 0.123 Partheen et al., 2006 
NPTX1 268 4.715 0.109 Bowen et al., 2009 
SLFN11 339 4.297 0.143 Bowen et al., 2009 
SLC44A3 385 9.558 0.128 Grasso et al., 2012 
EPDR1 413 3.801 0.199 Tomlins et al., 2007 
ANPEP 430 5.162 0.117 Taylor et al., 2010 
ITM2A 437 2.295 0.146 Partheen et al., 2006 
FA2H 453 2.277 0.162 Partheen et al., 2006 
CXCL6 548 3.598 0.190 Bowen et al., 2009 
EPB41L3 626 4.606 0.162 Taylor et al., 2010 
RASSF2 916 6.726 0.229 Varambally et al., 2005 
AKR1C3 1009 6.385 0.259 Varambally et al., 2005 
PLAT 1031 1.759 0.179 Partheen et al., 2006 
CA9 1049 1.747 0.191 Partheen et al., 2006 
SLITRK4 1304 2.319 0.198 Bowen et al., 2009 
TMEM27 1396 2.233 0.207 Bowen et al., 2009 
DOCK11 1544 2.094 0.206 Bowen et al., 2009 
SLC7A8 1694 1.382 0.216 Partheen et al., 2006 
TGFA 1728 1.364 0.234 Partheen et al., 2006 
FAM65B 1809 1.833 0.221 Bowen et al., 2009 
Supplementary Table 7. Tested associations between top ovarian cancer risk SNP rs757210 and CpG probes surrounding HNF1B in n=231 
HGS ovarian cancer samples with 450K methylation array data and Agilent gene expression data (Wang et al. 2014). Figure 3A is a graphical 




Probe Estimate Est. Lower CI Est. Upper CI Std Error p-value Genomic co-ordinate  Gene CpG Island 
cg11485655 0.0004386 -0.181 0.1819 0.09256 0.9962 36032204    
cg14694075 0.01047 -0.171 0.1919 0.09257 0.9101 36059830 HNF1B   
cg11866296 0.02437 -0.1564 0.2052 0.09225 0.7919 36061601 HNF1B   
cg04136369 -0.0699 -0.2509 0.1111 0.09237 0.45 36070600 HNF1B   
cg21250756 0.09241 -0.08699 0.2718 0.09154 0.3138 36077300 HNF1B   
cg16672659 -0.2385 -0.4161 -0.06097 0.09058 0.009039 36098223 HNF1B  N Shelf 
cg15246719 -0.08947 -0.2684 0.08943 0.09127 0.328 36102254 HNF1B  Island 
cg12134754 -0.03565 -0.217 0.1457 0.09254 0.7004 36102394 HNF1B  Island 
cg24712484 -0.1112 -0.2911 0.06877 0.09181 0.2272 36102575 HNF1B  Island 
cg03433642 -0.06439 -0.2432 0.1144 0.0912 0.4809 36102740 HNF1B  Island 
cg09679923 -0.05434 -0.2312 0.1226 0.09026 0.5478 36103036 HNF1B  Island 
cg17652435 -0.08159 -0.2587 0.09552 0.09036 0.3675 36103066 HNF1B  Island 
cg03348978 -0.04373 -0.2222 0.1348 0.09107 0.6315 36103230 HNF1B  Island 
cg02435495 -0.001038 -0.1805 0.1784 0.09155 0.991 36103289 HNF1B  Island 
cg05110178 -0.1313 -0.3083 0.0457 0.09032 0.1473 36103953 HNF1B  Island 
cg11862993 -0.09243 -0.2695 0.08469 0.09037 0.3075 36103978 HNF1B  Island 
cg04917276 -0.1633 -0.3396 0.01291 0.08992 0.07062 36104585 HNF1B  Island 
cg04433035 -0.1484 -0.3263 0.0294 0.09073 0.1032 36105064 HNF1B  N Shore 
cg05222347 -0.1119 -0.2898 0.06588 0.09073 0.2185 36105117 HNF1B  N Shore 
cg02335804 -0.1329 -0.3121 0.04632 0.09143 0.1475 36105239 HNF1B  N Shore 
cg12788467 -0.1815 -0.3603 -0.002777 0.09121 0.04774 36105335 HNF1B  Island 
cg13230606 -0.184 -0.3626 -0.005297 0.09116 0.04475 36105337 HNF1B  Island 
cg19378036 -0.1858 -0.3644 -0.007124 0.09114 0.04269 36105364 HNF1B  Island 
cg14487292 -0.1983 -0.3765 -0.02016 0.09091 0.03015 36105517 HNF1B  Island 
cg04198914 -0.1598 -0.3387 0.01917 0.09129 0.08147 36106025 HNF1B  S Shore 
cg16179589 0.05649 -0.1246 0.2376 0.0924 0.5416 36107292   S Shore 
Supplementary Table 8 A. Associations between top ovarian cancer SNP rs757210 and expression probes in the surrounding 1 Mb region 
(adjusted for age) in n=182 high-grade serous ovarian cancer cases with Agilent gene expression data and COGS genotypes (Wang et al. 2014) 
[9]. 
 
Probe Estimate Est. lower CI Est. upper CI Std error p-value Gene Genomic coordinates 
A_24_P109962 0.1452 -0.05837 0.3488 0.1039 0.1683  chr17: 35501096-35501060 
A_24_P330822 -0.1343 -0.3405 0.07181 0.1052 0.2032 HNF1B chr17: 36059175-36059116 
A_24_P878366 -0.1172 -0.3235 0.08902 0.1052 0.2667  chr17: 35846866-35846807 
A_23_P141434 -0.1034 -0.31 0.1031 0.1054 0.3278 ACACA chr17: 35445931-35444374 
A_23_P65157 0.1012 -0.1043 0.3067 0.1048 0.3357  chr17: 35766390-35766331 
A_23_P335388 0.08388 -0.1194 0.2872 0.1037 0.4198 C17orf78 chr17: 35749525-35749584 
A_32_P215318 0.08526 -0.1214 0.2919 0.1055 0.4199 ACACA chr17: 35687296-35687237 
A_24_P779605 0.07821 -0.1282 0.2847 0.1053 0.4588 SOCS7 chr17: 36561724-36561783 
A_32_P111852 0.0747 -0.1318 0.2812 0.1053 0.4791 SOCS7 chr17: 36561734-36561793 
A_23_P207537 -0.0716 -0.2774 0.1342 0.105 0.4962 DUSP14 chr17: 35873238-35873297 
A_32_P153423 -0.06752 -0.2737 0.1387 0.1052 0.5218 DDX52 chr17: 35970039-35969980 
A_24_P179033 -0.06636 -0.2729 0.1402 0.1054 0.5297  chr17: 35497926-35497867 
A_24_P1929 0.05743 -0.1494 0.2642 0.1055 0.869 DDX52 chr17: 35980949-35979857 
A_23_P351695 0.04789 -0.1587 0.2545 0.1054 0.6501 SYNRG chr17: 35901158-35901099 
A_32_P9575 -0.04296 -0.2486 0.1627 0.1049 0.6827 MRPL45 chr17: 36454586-36455369 
A_23_P164210 -0.04261 -0.2488 0.1636 0.1052 0.686 TBC1D3F chr17: 36294855-36294914 
A_24_P690235 -0.04018 -0.2464 0.1661 0.1052 0.7031 LOC440434 chr17: 36351939-36351880 
A_23_P66664 0.03686 -0.1697 0.2434 0.1054 0.7269 TADA2A chr17: 35822207-35825575 
A_23_P66658 0.031 -0.175 0.237 0.1051 0.7684 TADA2A chr17: 35836941-35837000 
A_23_P207557 0.0295 -0.1775 0.2365 0.1056 0.7083 HNF1B chr17: 36089085-36089026 
A_23_P207541 0.01806 -0.1887 0.2248 0.1055 0.8642 SYNRG chr17: 36089085-36089026 
A_23_P396626 0.01681 -0.186 0.2196 0.1035 0.8711 SYNRG chr17: 35878116-35878057 
A_23_P409287 0.01468 -0.199 0.2213 0.1054 0.8894 HNF1B chr17: 36046809-36046750 
A_24_P367211 0.01344 -0.1923 0.2192 0.105 0.8983 SOCS7 chr17: 36552120-36552179 
A_23_P118660 -0.00855 -0.2156 0.1985 0.1056 0.9356 DDX52 chr17: 35973928-35973869 
A_23_P113623 -0.006283 -0.2134 0.2008 0.1057 0.9527 MRPL45 chr17: 36478912-36478971 
A_32_P43711 0.002609 -0.2033 0.2085 0.1051 0.9802 SOCS7 chr17: 36555823-36555882 
Supplementary Table 8 B. Associations between top ovarian cancer SNP rs757210 and expression probes in the surrounding 1 Mb region 





Probe Estimate Est. lower CI Est. upper CI Std error p-value Gene Genomic co-ordinates 
A_ 24_P878366 -0.8491 -1.564 -0.1345 0.3646 0.03171  chr17: 035846866-035846807 
A_ 24_P690235 -0.8375 -1.566 -0.1087 0.3719 0.03702 LOC440434 chr17: 36351939-36351880 
A_ 23_P409287 0.6229 -0.01866 1.264 0.3273 0.07316 HNF1B chr17: 36046809-36046750 
A_ 23_P207557 0.5784 -0.04437 1.201 0.3177 0.08538 HNF1B chr17: 36089085-36089026 
A_24_P330822 0.5641 -0.09709 1.225 0.3373 0.1118 HNF1B chr17: 36059175-36059116 
A_23_P207537 0.5581 -0.2197 1.336 0.3969 0.1766 DUSP14 chr17: 35873238-35873297 
A_24_P1929 0.4903 -0.2439 1.224 0.3746 0.2070 DDX52 chr17: 35980949-35979857 
A_23_P335388 -0.4957 -1.263 0.2714 0.3914 0.2215 C17orf78 chr17: 35749525-35749584 
A_32_P153423 0.3599 -0.3726 1.092 0.3738 0.3483 DDX52 chr17: 35970039-35969980 
A_23_P118660 0.3594 -0.3903 1.109 0.3825 0.3599 DDX52 chr17: 35973928-35973869 
A_32_P215318 0.3511 -0.4593 1.161 0.4135 0.4070 ACACA chr17: 35687296-35687237 
A_23_P396626 0.325 -0.4314 1.081 0.3859 0.4108 SYNRG chr17: 35878116-35878057 
A_23_P66664 0.3202 -0.4453 1.086 0.3906 0.4231 TADA2A chr17: 35822207-35825575 
A_23_P141434 0.313 -0.4989 1.125 0.4142 0.4597 ACACA chr17: 35445931-35444374 
A_32_P43711 0.2611 -0.4939 1.016 0.3852 0.5065 SOCS7 chr17: 36555823-36555882 
A_23_P113623 0.274 -0.5245 1.073 0.4074 0.5097 MRPL45 chr17: 36478912-36478971 
A_32_P65157 -0.2124 -1.031 0.6065 0.4178 0.6173  chr17: 35766390-035766331 
A_24_P779605 0.1954 -0.6257 1.017 0.4189 0.6465 SOCS7 chr17: 36561724-36561783 
A_24_P179033 0.1599 -0.6539 0.9738 0.4152 0.7046  chr17: 35497926-035497867 
A_23_P351695 -0.1158 -0.8446 0.6131 0.3719 0.7591 SYNRG chr17: 35901158-35901099 
A_24_P367211 0.1147 -0.6922 0.9216 0.4117 0.7837 SOCS7 chr17: 36552120-36552179 
A_24_P109962 0.1045 -0.6732 0.8822 0.3968 0.7952  chr17: 35501096-35501060 
A_23_P207541 0.09772 -0.6488 0.8442 0.3809 0.8004 SYNRG chr17: 35875336-35875277 
A_32_P111852 0.102 -0.7234 0.9273 0.4211 0.8114 SOCS7 chr17: 36561734-36561793 
A_23_P66658 -0.05227 -0.8482 0.7437 0.4061 0.8990 TADA2A chr17: 35836941-35837000 
A_32_P9575 0.04265 -0.7782 0.8635 0.4188 0.9200 MRPL45 chr17: 36454586-36455369 
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